1. Home
  2. LIDR vs CRDL Comparison

LIDR vs CRDL Comparison

Compare LIDR & CRDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LIDR
  • CRDL
  • Stock Information
  • Founded
  • LIDR 2013
  • CRDL 2017
  • Country
  • LIDR United States
  • CRDL Canada
  • Employees
  • LIDR N/A
  • CRDL N/A
  • Industry
  • LIDR Auto Parts:O.E.M.
  • CRDL Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • LIDR Consumer Discretionary
  • CRDL Health Care
  • Exchange
  • LIDR Nasdaq
  • CRDL Nasdaq
  • Market Cap
  • LIDR 105.4M
  • CRDL 90.4M
  • IPO Year
  • LIDR N/A
  • CRDL N/A
  • Fundamental
  • Price
  • LIDR $3.11
  • CRDL $1.08
  • Analyst Decision
  • LIDR Strong Buy
  • CRDL Strong Buy
  • Analyst Count
  • LIDR 1
  • CRDL 2
  • Target Price
  • LIDR $6.00
  • CRDL $9.00
  • AVG Volume (30 Days)
  • LIDR 4.2M
  • CRDL 740.0K
  • Earning Date
  • LIDR 11-11-2025
  • CRDL 11-13-2025
  • Dividend Yield
  • LIDR N/A
  • CRDL N/A
  • EPS Growth
  • LIDR N/A
  • CRDL N/A
  • EPS
  • LIDR N/A
  • CRDL N/A
  • Revenue
  • LIDR $236,000.00
  • CRDL N/A
  • Revenue This Year
  • LIDR $1.50
  • CRDL N/A
  • Revenue Next Year
  • LIDR $2,806.06
  • CRDL N/A
  • P/E Ratio
  • LIDR N/A
  • CRDL N/A
  • Revenue Growth
  • LIDR N/A
  • CRDL N/A
  • 52 Week Low
  • LIDR $0.49
  • CRDL $0.77
  • 52 Week High
  • LIDR $6.44
  • CRDL $2.24
  • Technical
  • Relative Strength Index (RSI)
  • LIDR 64.54
  • CRDL 47.72
  • Support Level
  • LIDR $2.29
  • CRDL $1.04
  • Resistance Level
  • LIDR $3.28
  • CRDL $1.10
  • Average True Range (ATR)
  • LIDR 0.20
  • CRDL 0.05
  • MACD
  • LIDR 0.07
  • CRDL 0.00
  • Stochastic Oscillator
  • LIDR 79.29
  • CRDL 34.33

About LIDR AEye Inc.

AEye Inc is a provider of high-performance, active lidar systems for vehicle autonomy, driver-assistance systems (ADAS), and robotic vision applications. The company's software-definable 4Sight Intelligent Sensing Platform combines solid-state active lidar, an optionally fused low-light HD camera, and integrated deterministic artificial intelligence to capture more intelligent information with less data, enabling faster, more accurate, and more reliable perception of the surroundings. Majority of the Company's revenue is generated from customers located in the United States followed by Europe, and Asia-Pacific.

About CRDL Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's main product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart which are a Phase II multi-national trial, the ARCHER trial, in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis.

Share on Social Networks: